InsidersTradesSigma
Track the Spectrum Pharmaceuticals INC share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Spectrum Pharmaceuticals INC has published 55 reports. The latest transaction was disclosed on 1 August 2023 (Disposition). Among the most active insiders: McGahan Keith M. Every trade is openly available.
55
Insider Decl.
n/a
Thresholds
€21,793
1 ops.
Buy Volume
€297,303
34 ops.
Sell Volume
37Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 August 2023
Declarations55 total
27,380 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017680:0
54,066 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017672:0
295,244 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017668:0
317,474 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017669:0
29,759 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017677:0
104,823 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017673:0
67,660 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017675:0
195,485 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017679:0
463,005 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017673:1
32,387 shares@ US$1.096100.0% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-025014:0
15,733 shares@ US$0.81917.9% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-008619:0
18,153 shares@ US$0.81912.5% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-008618:0
11,990 shares@ US$0.76112.8% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-006112:0
14,607 shares@ US$0.7619.4% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-006110:0
69,389 shares@ US$0.54431.4% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-003144:0
26,138 shares@ US$0.54419.5% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-003145:0
23,929 shares@ US$0.3827.7% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-001066:0
222,000 shares0Common Stock, $0.001 par valueSEC:0000899243-23-001065:0
240,000 shares0Common Stock, $0.001 par valueSEC:0000899243-23-001064:0
50,000 shares@ US$0.4544.1% of flowCommon Stock, $0.001 par valueSEC:0000899243-22-037526:0
Canonical exit: 28 Feb 2023 (T+90)
50,000 shares@ US$0.4343.7% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-054744:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048515:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048520:0
27,380 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048497:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048461:0
25 of 55 declarations
About Spectrum Pharmaceuticals INC
Geographically, Spectrum has operated primarily from the United States and serves the U.S. market, with exposure to the country’s healthcare system, payers, and hospital distribution channels. SEC filings also show reliance on third-party manufacturers for certain inputs, active pharmaceutical ingredients, and logistics services, which is important when assessing operational resilience. In short, Spectrum Pharmaceuticals Inc. remains a U.S. biopharmaceutical stock listed on the NASDAQ, with a specialized and higher-risk profile, whose recent history has been defined by portfolio contraction, strategic refocusing, and greater dependence on a limited set of clinical and commercial catalysts.
